Tanja D de Gruijl (T D de Gruijl)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

Pharmaceutics

Oncoimmunology

VU medisch centrum

VU University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

VU medisch centrum Aug 01 2013

Netherlands

Professor of Translational Tumor Immnology :: Medical Oncology

VU medisch centrum Jan 04 2009 - Jul 31 2013

Netherlands

Associate Professor :: Medical Oncology

VU medisch centrum Mar 15 1998 - Mar 01 2009

Netherlands

Postdoc/scientist :: Medical Oncology

Education History

VU University Mar 15 1992 - Jan 14 1998

Netherlands

PHD :: Pathology

University of Utrecht Sep 01 1986 - Feb 15 1992

Netherlands

MSC

Publications

Aram M de Haas, Dorian A Stolk, Sjoerd T T Schetters, Laura Goossens-Kruijssen, Eelco Keuning, Martino Ambrosini, Louis Boon, Hakan Kalay, Gerrit Storm, Hans J van der Vliet, Tanja D de Gruijl, Yvette van Kooyk
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells. Pharmaceutics 16 (5) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Aram M de Haas, Dorian A Stolk, Sjoerd T T Schetters, Laura Goossens-Kruijssen, Eelco Keuning, Martino Ambrosini, Louis Boon, Hakan Kalay, Gerrit Storm, Hans J van der Vliet, Tanja D de Gruijl, Yvette van Kooyk
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells. Pharmaceutics 16 (5) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Elisabetta Michielon, Marta López González, Dorian A Stolk, Joeke G C Stolwijk, Sanne Roffel, Taco Waaijman, Sinéad M Lougheed, Tanja D de Gruijl, Susan Gibbs
A Reconstructed Human Melanoma-in-Skin Model to Study Immune Modulatory and Angiogenic Mechanisms Facilitating Initial Melanoma Growth and Invasion. Cancers 15 (10) (2023)
Lisa A King, Elisa C Toffoli, Myrthe Veth, Victoria Iglesias-Guimarais, Manon C Slot, Derk Amsen, Rieneke van de Ven, Sarah Derks, Marieke F Fransen, Jurriaan B Tuynman, Thilo Riedl, Rob C Roovers, Anton E P Adang, Jurjen M Ruben, Paul W H I Parren, Tanja D de Gruijl, Hans J van der Vliet
A bispecific γδ T-cell engager targeting EGFR activates a potent Vγ9Vδ2 T cell-mediated immune response against EGFR-expressing tumors. Cancer immunology research (2023)
Elisabetta Michielon, Tanja D de Gruijl, Susan Gibbs
From simplicity to complexity in current melanoma models. Experimental dermatology 31 (12) (2022)
Kim M van Pul, Jessica C L Notohardjo, Marieke F Fransen, Bas D Koster, Anita G M Stam, Dafni Chondronasiou, Sinéad M Lougheed, Joyce Bakker, Vinitha Kandiah, M Petrousjka van den Tol, Karin Jooss, Ronald J C L M Vuylsteke, Alfonsus J M van den Eertwegh, Tanja D de Gruijl
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic T reg reduction and effector T cell activation. Science immunology 7 (73) (2022)
Kim M van Pul, Ronald J C L M Vuylsteke, Monique T A de Beijer, Rieneke van de Ven, M Petrousjka van den Tol, Hein B A C Stockmann, Tanja D de Gruijl
Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway. Journal for immunotherapy of cancer 8 (2) (2021)
Elisabetta Michielon, Marta López González, Judith L A Burm, Taco Waaijman, Ekaterina S Jordanova, Tanja D de Gruijl, Susan Gibbs
Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10. Cancer immunology, immunotherapy : CII 69 (11) (2020)
Alsya A Affandi, Joanna Grabowska, Katarzyna Olesek, Miguel Lopez Venegas, Arnaud Barbaria, Ernesto Rodríguez, Patrick P G Mulder, Helen J Pijffers, Martino Ambrosini, Hakan Kalay, Tom O'Toole, Eline S Zwart, Geert Kazemier, Kamran Nazmi, Floris J Bikker, Johannes Stöckl, Alfons J M van den Eertwegh, Tanja D de Gruijl, Gert Storm, Yvette van Kooyk, Joke M M den Haan
Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes. Proceedings of the National Academy of Sciences of the United States of America 117 (44) (2020)
Marta López González, R van de Ven, H de Haan, J van Eck van der Sluijs, W Dong, V W van Beusechem, Tanja D de Gruijl
Oncolytic adenovirus ORCA-010 increases the type 1 T cell stimulatory capacity of melanoma-conditioned dendritic cells. Clinical and experimental immunology 201 (2) (2020)
Kim M van Pul, Ronald J C L M Vuylsteke, Rieneke van de Ven, Elisabeth A Te Velde, Emiel J Th Rutgers, Petrousjka M van den Tol, Hein B A C Stockmann, Tanja D de Gruijl
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node. Journal for immunotherapy of cancer 7 (1) (2019)
Bas D Koster, Saskia J A M Santegoets, Jorien Harting, Arnold Baars, S Marieke van Ham, Rik J Scheper, Erik Hooijberg, Tanja D de Gruijl, Alfonsus J M van den Eertwegh
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial. Cancer immunology, immunotherapy : CII 68 (6) (2019)
Hester J Scheffer, Anita G M Stam, Bart Geboers, Laurien G P H Vroomen, Alette Ruarus, Beaunelle de Bruijn, M Petrousjka van den Tol, Geert Kazemier, Martijn R Meijerink, Tanja D de Gruijl
Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation. Oncoimmunology 8 (11) (2019)
A N Niemeijer, D Leung, M C Huisman, I Bahce, O S Hoekstra, G A M S van Dongen, R Boellaard, S Du, W Hayes, R Smith, Albert D Windhorst, N H Hendrikse, A Poot, D J Vugts, E Thunnissen, P Morin, D Lipovsek, D J Donnelly, S J Bonacorsi, L M Velasquez, Tanja D de Gruijl, E F Smit, A J de Langen
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer. Nature communications 9 (1) (2018)

Tanja D de Gruijl.css-eqlu8i{font-size:small;padding-left:4px;} (T D de Gruijl)

Publication Activity (10 Years)

Top Topics

Top Venues

Tanja D de Gruijl (T D de Gruijl)